Sunhee Kwon is an accomplished professional in the field of biometrics, currently serving as Senior Vice President at Nurix Therapeutics since May 2025 and as Vice President, head of Biometrics at Prelude Therapeutics since July 2023. Prior experience includes roles as Vice President, head of Biometrics at Sierra Oncology from February 2021 to July 2023, and Executive Director of Biostatistics at BeiGene from February 2017 to January 2021. Sunhee also served as Director of Global Biostatistical Sciences, Oncology at Amgen from June 2015 to January 2017, where oversight included global statistical leadership for Kyprolis. Educational qualifications include a Ph.D. in Statistics from Iowa State University and both MS and BS degrees in Statistics, as well as a BS in Computer Science/Statistics from Seoul National University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices